Location of Repository

Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality

By M.J. (Michael J.) Mina, C.J.E. (C. Jessica E.) Metcalf, R.L. (Rik) de Swart, A.D.M.E. (Albert) Osterhaus and B.T. (Bryan) Grenfell

Abstract

Immunosuppression after measles is known to predispose people to opportunistic infections for a period of several weeks to months. Using population-level data, we show that measles has a more prolonged effect on host resistance, extending over 2 to 3 years. We find that nonmeasles infectious disease mortality in high-income countries is tightly coupled to measles incidence at this lag, in both the pre- and post-vaccine eras. We conclude that long-term immunologic sequelae of measles drive interannual fluctuations in nonmeasles deaths. This is consistent with recent experimental work that attributes the immunosuppressive effects of measles to depletion of B and T lymphocytes. Our data provide an explanation for the long-term benefits of measles vaccination in preventing all-cause infectious disease. By preventing measles-associated immune memory loss, vaccination protects polymicrobial herd immunity

Year: 2015
DOI identifier: 10.1126/science.aaa3662
OAI identifier: oai:repub.eur.nl:87260
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://repub.eur.nl/pub/87260 (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.